It has recently been shown that the neurological mutant mouse staggerer (sg) harbors a deletion within the Rora gene that encodes the orphan nuclear receptor RORa. This deletion removes an exon encoding part of the ligand binding domain of the putative receptor, generating an RORa truncated protein (RORa sg ). It is unknown whether sg acts as a null or highly hypomorphic allele. To address this question, we have generated a null mutation of Rora by targeted disruption of its DNA binding domain in ES cells. The Rora −/− mice are viable but display tremor, body imbalance, small size and die between 3-4 weeks, similar to the sg mouse. Histological examination of the cerebellum of Rora −/− and sg mice showed similar defects, including small size and fewer ectopically localized Purkinje cells. Northern blot analysis of cerebellar RNA showed that RORa transcripts are still expressed in the Rora −/− and sg mutants, although with altered mobilities.
Introduction
The superfamily of nuclear hormone receptors is composed of ligand-dependent transcription factors as well as a large number of orphan members for which no ligands have been found. Nuclear receptors have a common modular structure composed essentially of a DNA binding domain (DBD), a ligand binding domain (LBD) and transactivation or -repression domains (reviewed in . These proteins regulate gene transcription by binding to specific DNA sequences, referred to as hormone response element (HRE), located in the promoter and enhancer regions of their target genes (Evans, 1988; Beato, 1989) . The transcriptional function of nuclear hormone receptors is not limited to their ability to bind DNA with a high affinity but can also be transduced through direct protein:protein interactions with other transcription factors or associated co-factors (Beato and Sánchez-Pacheco, 1996; Horwitz et al., 1996; Kamei et al., 1996) . Thus, through specific modulation of gene expression, nuclear receptors control cellular processes implicated in embryonic development, cell fate and differentiation and homeostasis Kastner et al., 1995; Thummel, 1995) .
The RORa gene products belong to the class of orphan nuclear receptors. The RORa gene (Rora) generates multiple isoforms (RORa1-4) that share a common DBD and LBD but contain distinct amino-terminal domains that have been shown to modulate their DNA-binding activity (Giguère et al., , 1995b McBroom et al., 1995) . RORa isoforms bind as monomers to HREs known as ROREs and constitutively activate heterologous promoters containing one or many copies of a RORE when assayed in transient transfections Greiner et al., 1996; Medvedev et al., 1996; Dussault and Giguère, 1997) .
However, the physiologic role of these proteins are still poorly understood. Recent work identifying the N-myc gene as a direct target of RORa (Dussault and Giguère, 1997) and demonstrating changes in RORa expression during P19 embryocarcinoma cell differentiation (Matsui et al., 1995) suggests a role for this orphan nuclear receptor in neuronal differentiation.
The neurological mutant mouse staggerer (sg) was first described 35 years ago (Sidman et al., 1962) and the affected allele subsequently mapped to mouse chromosome 9 (Green and Lane, 1967) . Homozygotes show tremor, body imbalance, hypotonia as well as small size and die shortly after weaning. The cerebellar cortex of sg mice exhibits a cell-autonomous defect of the Purkinje cells which are small, abnormal in morphology and reduced by 60-90% in numbers. The effects of the mutation show a regional variation in the size of the remaining Purkinje cells along a mediolateral axis. Furthermore, failure of synaptic contact between Purkinje cell dendrites and granule cell parallel fibers lead to granule cell loss (Herrup and Mullen, 1979; Herrup, 1983) . Recently, the gene encoding RORa was shown to reside on mouse chromosome 9 in proximity to the sg gene (Giguère et al., 1995a) , and genetic and physical mapping localized sg to an interval of 160 kb containing Rora (Hamilton et al., 1996; Matysiak-Scholze and Nehls, 1997) . The gene encoding RORa in sg mice harbors a 6.5 kb genomic deletion removing an exon that encodes part of its LBD. The resulting exon-skipping event causes a shift in the reading frame and introduces a premature stop codon, thereby producing a novel RORa1 truncated protein lacking Top, the wild-type locus. The black box represents the exon encoding the first zinc finger of the RORa DBD. The fragment used to probe Southern blots (probe 'E') is indicated. Center, the targeting vector pKOinsEIII. Bottom, the structure of the disrupted Rora locus showing insertion of the neo cassette in the RORa DBD. The genomic fragments detected by probe 'E' (BamHI digestion) are illustrated. (B) Southern blot analysis of a litter from a heterozygote intercross. Genomic DNA was digested with BamHI and probe 'E' was used to distinguish wild-type and mutant alleles. B, BamHI; Bg, BglII; E, EcoRI; S, SstI; neo, neomycin; tk, thymidine kinase. a complete LBD, herein referred to as RORa sg . The function of the mutant RORa sg protein has not been studied; however, we have previously demonstrated that RORa1 proteins deleted of their LBD are able to bind DNA with high affinity and specificity but display no transcriptional activity (Giguère et al., 1995b; McBroom et al., 1995) . This suggests that RORa sg could act as a competitor for DNA binding on ROREs and/or interfere with co-regulator functions required for the activity of other nuclear receptors. Therefore, the aim of the present work was to test whether sg acts as a null or hypomorphic allele. To this end, we have generated a null mutation of Rora by disrupting its DBD using homologous recombination in ES cells. The results of these experiments show that the absence of functional RORa is responsible for the sg defect.
Results

Generation of Rora null mutant mice
An Rora clone was isolated from a genomic library derived from the 129/Sv strain and used to construct the targeting vector. Fig. 1A shows the wild-type Rora locus, the targeting vector and the targeted alleles. The targeting vector consists of an insertion of the neomycin cassette, disrupting exon III of Rora. This exon encodes the first zinc finger of the DBD and is common to all RORa isoforms. The homologous recombination is thus predicted to disrupt the DNA binding ability of all RORa isoforms, producing a null mutation.
The Rora targeting vector was introduced into ES cells and a clone with a disrupted allele was micro-injected into blastocysts. A chimeric male mouse transmitted the mutation to its offspring. Heterozygous mice appeared normal and were crossed to obtain homozygous mutant mice. Fig.  1B shows a representative Southern blot of offspring from heterozygous mice. Genomic DNA digested with BamHI and hybridized with a 3′ flanking probe detected a 7.5-kb fragment for wild-type and a 9.5-kb for the knock-out allele.
Rora
−/− homozygous have cerebellar defects similar to
Rora sg/sg mice
Crosses between heterozygous mice produced offspring that were born with the expected Mendelian distribution, indicating that the absence of RORa is not lethal in utero (data not shown). However, the Rora −/− mice had tremor, abnormal body balance and died between 24-28 days, features consistent with the neurological mutant Rora sg/sg
. The gross and histological features of the cerebella of the homozygous Rora −/− mutants were therefore compared with that of Rora sg/sg mice. Fig. 2 shows paraffin sections of a 21-dayold wild-type and mutant cerebella stained with hematoxylin and eosin. The normal cerebellum is composed of three well-defined layers of neurons forming the grey matter which surrounds the white matter ( Fig. 2A) . In the grey matter, prominent Purkinje cells separate the external molecular layer from the granular layer (Fig. 2B,C) . Structural features of the cerebella of the Rora −/− homozygous mice and Rora sg/sg mice were indistinguishable (compare D,E,F with J,K,L in Fig. 2) . Analysis of a large number of brains obtained from both groups of mice showed that their cerebella were several times smaller than wild-type with abnormal Purkinje cells. The latter were smaller than wild-type, significantly reduced in numbers and ectopically located (Fig. 2F,L) . To test whether the genetic alterations in Rora -and Rora sg alleles could complement one another, Rora −/+ and Rora sg/+ mice were intercrossed. Histological examination of the cerebellum of Rora −/sg showed comparable defects to both Rora −/− and Rora sg/sg mice (Fig.  2G,H,I ).
Expression of Rora, Rorb and Rorg in Rora mutants
To study whether the different genetic alterations in Rora −/− and Rora sg/sg generate a null or severe hypomorphic allele, we first monitored the expression of Rora in the cerebellum of the different mutants by Northern blot hybridization. Total RNA was isolated from the cerebellum of 21-day-old mice and hybridized with a specific Rora probe. The results show that both Rora −/− and Rora sg/sg mutants expressed Rora transcripts, although to a lower level than wild-type (Fig. 3) . Although the size of the Rora −/− transcript is predicted to be larger by approximately 1.5 kb , Rora −/sg and Rora sg/sg mice. Ten micrograms of total RNA were loaded per lane. The blot was hybridized to a probe consisting of a 918 bp SstI fragment of the RORa cDNA encompassing the DBD, hinge region and part of the LBD. The blot was also probed with a RORb (a 1-kb BamHI/HindIII fragment), RORg (a 1.3-kb BstXI fragment) and a neo probe. than the wild-type transcript, their apparent mobilities appear similar because of their very large size (Ͼ10 kb). To further verify that the transcripts expressed in Rora −/− mutants have their coding sequence interrupted by the insertion of the neomycin cassette, we probed the same blot with a specific neo probe. We found that neo was expressed in Rora −/+ and Rora −/sg mice and, as expected, that the level of neo expression was approximately doubled in Rora −/− mice.
We also hybridized the blot with probes specific to the genes encoding the closely related orphan nuclear receptors RORb (Rorb) and RORg (Rorg) to test whether these could compensate for the loss of RORa activity. While Rorg transcripts were undetectable in either wild-type or mutant mice (data not shown), we saw no evidence that the Rorb transcript was up-regulated in the mutant mice. In contrast, we observed a slight reduction in this transcript in the Rora sg/sg background (Fig. 3) . These results suggest that changes in the expression of these two related family members do not compensate for the loss of RORa activity in the cerebellum of Rora −/− and Rora sg/sg mice. However, it is unclear why the levels of Rorb are different in Rora −/− and Rora sg/sg mice. It is possible that the RORa sg protein specifically interferes with the normal regulation of Rorb.
To ensure that the targeting event produces a truly null mutant, Rora −/− mice were examined for residual RORa protein.
Immunohistochemistry was performed onto paraffin sections of cerebellum of 21-day-old mice, using an affinity purified polyclonal antibody directed against the RORa LBD (B. Varnum, unpublished data). This antibody specifically stained Purkinje cells as judged by the lack of immunoreactivity of the pre-immune serum (Fig. 4A ). As shown in Fig. 4B , the Purkinje cells within the cerebellum are intensely stained by the antibody against RORa in wildtype mice. No RORa protein, however, could be detected by the antibody in the Rora −/− cerebella (Fig. 4C ). These results demonstrate that the Rora −/− mice are true null mutants.
Discussion
In this study, we have investigated whether sg is a null or hypomorphic allele by generating RORa-deficient mice using gene targeting technology. The null mutation in Rora reproduces the defects previously observed in the cerebella of sg mice. Specifically, both mutations perturb the development of the cerebellum and result in tremor and body imbalance in the affected mice.
The truncated RORa sg protein generated by translation of the sg transcript contains all the determinants required for DNA-binding and a number of functional domains previously implicated in nuclear receptor and co-regulator interactions (Hamilton et al., 1996; Matysiak-Scholze and Nehls, 1997) . Consequently, the mutant RORa sg protein could compete for DNA binding sites or could sequester co-regulators present in limiting amounts, and therefore interfere with the normal function of other nuclear receptors or transcription factors active during Purkinje cell maturation. In addition, RORa sg lacks the main activation function 2 (AF-2) located at the carboxy-terminal end of the LBD and could therefore act as a dominant negative receptor. To address this question, we directly compared the cerebellar defects of sg with those observed in the RORa-deficient mice. The Rora −/− mouse does not express RORa in Purkinje cells, suggesting that these mice are true null mutants. We found that the gross morphological defects in the cerebella of the Rora sg/sg and the Rora −/− mice were similar, an observation that clearly demonstrates that the defects seen in the cerebella of sg animals are a direct consequence of the loss of RORa function, rather than the result of transcriptional interference causes by the mutant RORa sg . Further comparative molecular and cellular analysis of Rora −/− and Rora sg/sg mice may reveal more subtle differences between the two mutant alleles and may provide additional insight into the molecular mechanisms of RORa action in the development of the nervous system.
RORa is an orphan member of the nuclear hormone receptor family that was originally identified based on its sequence homology to the retinoic acid receptor . Elucidation of its physiological functions has come so far from structure/function studies (Forman et al., 1994; Giguère et al., 1994; Retnakaran et al., 1994; Giguère et al., 1995b; McBroom et al., 1995) , identification of target genes (Tini et al., 1995; Schräder et al., 1996; Dussault and Giguère, 1997) and phenotypic analysis of mutant mice carrying natural or synthetic mutations in the Rora locus (this study and Giguère et al., 1995a; Hamilton et al., 1996; Matysiak-Scholze and Nehls, 1997) . These mutations most dramatically affect the maturation of Purkinje cells in the cerebellum, but a number of other defects, especially in the immune system, have also been identified in sg (Kopmels et al., 1990; Bakalian et al., 1992; Kopmels et al., 1992) and Rora −/− mice (Dussault and Giguère, unpublished data) . It will therefore be of interest to investigate whether the two mutants display differences in other organ physiology due to the presence of truncated RORa protein in sg mice. Natural mutations leading to neuronal loss or abnormality in the cerebellum have been extensively studied as they are useful tools in understanding neuronal development and as they may model human hereditary diseases such as olivopontocerebellar atrophy (OPCA) and Friedreich's ataxia (Johnson, 1995; Montermini et al., 1995) . The finding that the presence of RORa is essential for Purkinje cell maturation provide important new insights into the complex processes leading to neuronal differentiation and suggest that putative natural or synthetic RORa ligands may be useful for treatment of specific CNS diseases.
Material and methods
Construction of targeting vector
Genomic Rora clones were isolated from a l phage library constructed from 129/Sv-derived DNA. A BglII (3.5 kb) fragment containing the 3′ region of exon III and parts of the downstream intron was cloned into the BamHI restriction site of pPNT, creating pPNT3.5Bgl. A blunted 4.5 kb BglII fragment containing the 5′ region of exon III and the upstream intron sequence was then cloned into the blunted XhoI site of pPNT3.5Bgl to create the insertion vector pKOinsEIII.
Gene targeting in ES cells
pKOinsEIII was linearized with NotI and electroporated into R1 ES cells. Resistant cells selected in G418 (150 mg/ ml effective concentration) and gancyclovir (2 mM) were picked, expanded and DNA was prepared for genomic Southern blot analysis to detect homologous recombination events. ES cells from one targeted line were injected into Balb\C blastocysts to generate chimeric mice according to published protocols (Papaioannou and Johnson, 1993) . A chimeric male mouse was mated with ICR females to generate heterozygous RORa-deficient mice. Heterozygous mice were mated and their progeny analyzed. Animals were genotyped by Southern blot analysis at 21 days using genomic DNA from tails. A 1 kb BglII/EcoRI fragment located downstream of the right arm of the targeting vector detected a 7.5 kb wild-type and a 9.5 kb knock-out band after digestion with BamHI (see Fig. 1 ). 
Northern blot analysis and immunohistochemistry
Animals were sacrificed by cervical dislocation at 21 days. Their cerebellum was removed and the RNA was isolated using Trizol (Gibco) according to the manufacturer's instructions, or fixed in 4% paraformaldehyde and prepared for immunohistochemistry. For Northern blot analysis, 10 mg of total RNA were loaded per lane into a 1% agarose/formaldehyde gel, transferred to Hybond-N (Amersham) membrane and hybridized with probes specific for RORa (a 918-bp Sst1 fragment), b (a~1-kb BamH1/HindIII fragment), g (a~1.3-kb BstX1 fragment) and neo probes under stringent conditions as described (Fawcett et al., 1995) . For immunohistochemistry, paraffin sections were rehydrated, treated with 0.1% trypsin and incubated with an affinity purified rabbit anti-mouse RORa1 LBD (RORa1 amino acid 270-523) polyclonal antibody in 1:100 dilution. The antibody was a gift from Dr. Brian Varnum, Amgen Inc., Thousand Oaks, CA. Washings, incubation with the secondary antibody and detection were performed according to the manufacturer's instructions (Dako).
